BETHESDA, Md.--(BUSINESS WIRE)--GE Capital, Healthcare Financial Services, announced today that it has recently provided a $2.5 million senior secured credit facility to SynGen, Inc., a medical device company with a 510(k) approved bench-top system for isolating stem cells from umbilical cord blood, peripheral blood and bone marrow. GE Capital, Healthcare Financial Services is acting as administrative agent for the credit facility. The financing will be used to support the company’s commercialization efforts.
Help employers find you! Check out all the jobs and post your resume.
